Cargando…

A case for new therapy for diabetes, is it leptin?

Detalles Bibliográficos
Autor principal: Kalra, Satya P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602978/
https://www.ncbi.nlm.nih.gov/pubmed/23565484
http://dx.doi.org/10.4103/2230-8210.105566
_version_ 1782263607173578752
author Kalra, Satya P.
author_facet Kalra, Satya P.
author_sort Kalra, Satya P.
collection PubMed
description
format Online
Article
Text
id pubmed-3602978
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36029782013-04-05 A case for new therapy for diabetes, is it leptin? Kalra, Satya P. Indian J Endocrinol Metab Editorial Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3602978/ /pubmed/23565484 http://dx.doi.org/10.4103/2230-8210.105566 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Kalra, Satya P.
A case for new therapy for diabetes, is it leptin?
title A case for new therapy for diabetes, is it leptin?
title_full A case for new therapy for diabetes, is it leptin?
title_fullStr A case for new therapy for diabetes, is it leptin?
title_full_unstemmed A case for new therapy for diabetes, is it leptin?
title_short A case for new therapy for diabetes, is it leptin?
title_sort case for new therapy for diabetes, is it leptin?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602978/
https://www.ncbi.nlm.nih.gov/pubmed/23565484
http://dx.doi.org/10.4103/2230-8210.105566
work_keys_str_mv AT kalrasatyap acasefornewtherapyfordiabetesisitleptin
AT kalrasatyap casefornewtherapyfordiabetesisitleptin